Company File · BSE 500124 · Latest filing Q1 FY27
Standalone = this company only. Consolidated = including its subsidiaries.
Dr. Reddy's Laboratories Ltd.
Data as of 19 Oct 2026 close · BSE · Latest results Q1 FY27
ISIN INE089A01031 · DRREDDY · Healthcare › Pharmaceuticals & Biotechnology
About the business
What does Dr. Reddy's do? Dr. Reddy's Laboratories is a large Hyderabad-based drug maker. It sells generic medicines in the US, Europe & emerging markets, branded medicines in India & Russia, & active pharmaceutical ingredients (APIs) to other drug makers. What is an API? The key chemical ingredient in a medicine. In 2024 it bought Nestle's consumer health brands such as Nicotinell.
Price & valuation · BSE close, 19 Oct 2026
Above its usual level
- Sales growth
- −5.5%
- Profit growth
- −69.1%
- Op. margin
- 10.6%
- P/E
- 32.1×
- Usual P/E
- 19.5×
- Price/book
- 2.71×
- ROCE
- 13.9%
- ROE
- 11.5%
- Debt/equity
- 0.16×
Earnings callsNo earnings-call transcript from Dr. Reddy's Laboratories in our data yet. When it files one on BSE, the call notes appear here within a few hours. See its call page
Is it expensive, and is it a good business?
Key ratios
In short Priced above its own usual level (P/E 32.1× vs 19.5×), earns moderate returns on capital (ROCE 13.9%) and has modest borrowings (debt to equity 0.16×).
What you pay Valuation
Buyers pay about ₹32 for every ₹1 the company earned per share over the last year. Above its 1-year median of 19.5×.
Latest BSE close ÷ last four quarters' basic EPS. As of 19th October 2026.
The share price is 2.7 times the accounting value of each share. Below its 1-year median of 2.8×.
Latest BSE close ÷ book value per share (equity ÷ shares) on the latest balance-sheet date. As of 19th October 2026.
The market values the company at 3.1 times its yearly sales.
Market value ÷ last 12 months' revenue. As of 19th October 2026.
The whole business (shares plus debt, minus cash) is valued at about 20.7 years of its operating profit.
Enterprise value ÷ last 12 months' EBITDA. As of 19th October 2026.
EPS fell 25.7% over the latest financial year vs the year before, from ₹67.89 to ₹50.41 a share, so PEG does not apply.
P/E ÷ 12-month EPS growth in % (the last four quarters vs the four before; when those are not all held, the latest financial year vs the year before). Growth above 100% counts as 100%; left blank when EPS fell or was below ₹1 a share a year earlier. Without one-off items when either year has large ones, as for the P/E. As of 19th October 2026.
The company paid ₹8.00 a share in the last 12 months (1 payout), 0.64% of today's share price.
Dividends per share with an ex-date in the last 12 months (restated for any split or bonus since) ÷ the latest BSE close. As of 19th October 2026.
How well it uses money Returns & strength
Each ₹100 of shareholders' money and debt earned about ₹13.9 before interest & tax.
Last 12 months' profit before interest & tax ÷ average (equity + borrowings). As of 31st March 2026.
For every ₹100 of shareholders' money, the company earned about ₹11.5 in a year.
Last 12 months' profit after tax (continuing operations where reported) ÷ average equity. As of 31st March 2026.
Needs reported tax expense that reconciles with profit; not yet available for these periods.
Last 12 months' operating profit after tax (profit before interest & tax × (1 − effective tax rate)) ÷ average invested capital (equity + borrowings − cash & bank balances). As of 31st March 2026.
Every ₹1 of assets generated about ₹0.63 of sales in a year.
Last 12 months' revenue ÷ average total assets. As of 31st March 2026.
Operating profit covered interest costs about 11 times.
Last 12 months' profit before interest & tax ÷ finance costs. As of 30th June 2026.
For every ₹1 of shareholders' money, it has borrowed ₹0.16.
Borrowings ÷ shareholders' equity on the latest balance-sheet date. As of 31st March 2026.
Who owns it Ownership & more
No verified shareholding pattern yet.
Promoter & promoter group shareholding from the latest shareholding pattern filed with BSE.
Needs two consecutive shareholding patterns.
Latest quarter's promoter holding minus the previous quarter's.
No verified shareholding pattern yet.
Promoter group shares pledged ÷ all the promoter group's shares, from the shareholding pattern filed with BSE each quarter (other encumbrances, such as non-disposal undertakings, are not counted).
After paying for new plant & equipment, operations left ₹3,343 crore of cash.
Cash from operations − spending on plant & equipment, latest full year. As of 31st March 2026.
Free cash flow, year by year
- FY26₹3,343 Cr
- FY25₹1,892 Cr
Each share has a face (nominal) value of ₹1. It matters for dividends quoted as a percentage, not for valuation.
Face value per share as BSE lists it today.
About 83.46 crore shares were in issue.
BSE's count of listed shares (BSE's market cap ÷ its price), so splits, bonuses & new shares since the latest results are included. As of 19th October 2026.
Your ratios
Ratios you added. Your choices are remembered on this device.
The stock market values the company at about ₹1,03,662 crore.
Latest BSE close × BSE's count of listed shares. As of 19th October 2026.
Buying the whole business, including its debt and keeping its cash, would cost about ₹1,06,607 crore.
Market value + borrowings − cash & bank balances. As of 19th October 2026.
The company reported ₹3,183 crore of profit over the last four quarters.
Sum of the last four quarters' reported profit after tax. As of 30th June 2026.
Each share earned about ₹38.69 over the last year.
Sum of the last four quarters' basic EPS. As of 30th June 2026.
Each share is backed by about ₹458 of net assets on the books.
Shareholders' equity ÷ shares. As of 31st March 2026.
About ₹15.5 of every ₹100 of sales was left after running costs.
EBITDA ÷ revenue over the last four quarters. As of 30th June 2026.
About ₹5.4 of every ₹100 of sales became profit last quarter.
Profit after tax ÷ revenue for the latest quarter. As of 30th June 2026.
Sales were 5.5% lower than a year earlier.
Latest quarter's revenue vs the same quarter last year. As of 30th June 2026.
Profit was 69.1% lower than a year earlier.
Latest quarter's profit after tax vs the same quarter last year (continuing operations when a one-off discontinued item exists). As of 30th June 2026.
Short-term assets cover short-term bills 1.80 times.
Current assets ÷ current liabilities. As of 31st March 2026.
Customers take about 110 days to pay.
Trade receivables ÷ last 12 months' revenue × 365. As of 31st March 2026.
Stock on hand equals about 83 days of sales.
Inventories ÷ last 12 months' revenue × 365. As of 31st March 2026.
35.3% of pre-tax profit came from other income (interest, dividends, gains).
Other income ÷ profit before tax, last 12 months. As of 30th June 2026.
Each ₹1 of profit brought in ₹1.36 of operating cash.
Latest full year's cash from operations ÷ profit after tax. As of 31st March 2026.
Borrowings exceed cash by ₹2,945 crore.
Cash & bank balances − borrowings. As of 31st March 2026.
Needs reported tax expense that reconciles.
Tax expense ÷ profit before tax (continuing operations), last 12 months. As of 30th June 2026.
Everything the company owns earned 7.7% in a year.
Last 12 months' profit ÷ average total assets. As of 31st March 2026.
Operating profit before interest, depreciation & tax was ₹5,140 crore.
Revenue − expenses + finance costs + depreciation, last four quarters. As of 30th June 2026.
Needs five financial years of cash flows.
Sum over five financial years of (cash from operations − capital expenditure).
The company spent ₹2,331 crore on plant & equipment.
Purchase of property, plant & equipment, latest full year. As of 31st March 2026.
Borrowings stood at ₹6,294 crore.
Current + non-current borrowings. As of 31st March 2026.
No verified shareholding pattern yet.
Foreign institutional holding from the latest shareholding pattern.
No verified shareholding pattern yet.
Domestic institutional holding (mutual funds, insurers, banks, pension funds).
The highest price in the last year was ₹1,414.4.
Highest intraday BSE price in the last 12 months (raw, not adjusted). As of 29th June 2026.
The lowest price in the last year was ₹1,080.05.
Lowest intraday BSE price in the last 12 months (raw, not adjusted). As of 23rd July 2026.
The share price moved -3.2% over the last year.
Close today ÷ close a year ago − 1 (raw prices, dividends not included). As of 19th October 2026.
About 21% of the last year's earnings per share was paid out as dividends.
Dividends per share with an ex-date in the last 12 months ÷ the last four quarters' EPS. As of 30th June 2026.
Needs four financial years of results (three years of growth).
Compound annual growth in revenue over three financial years.
Needs four financial years of results (three years of growth).
Compound annual growth in profit after tax over three financial years.
Tap the i beside any ratio for a plain explanation.
How these are worked out
Price-based ratios use the latest BSE close (19th October 2026). Share count 83.46 crore, from paid-up capital in the 19th October 2026 filing. Figures are consolidated.
What you pay: Higher numbers mean you pay more for each rupee the company earns or owns.
How well it uses money: Higher returns mean each rupee in the business earns more. Lower debt means less strain.
Who owns it: A steady promoter stake with nothing pledged is a calm sign.
+ Add your own ratios
Your choices are remembered on this device.
Last 4 quarters ₹ crore · Consolidated
| ₹ crore | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|
| Revenue from operations | 8,828 | 8,753 | 7,546 | 8,100 |
| EBITDA | 2,010 | 1,887 | 382.5 | 859.9 |
| Operating margin | 22.8% | 21.6% | 5.1% | 10.6% |
| Profit after tax | 1,337 | 1,190 | 221.3 | 435.6 |
| Basic EPS (₹) | 16.18 | 14.53 | 2.65 | 5.33 |
Latest filings BSE
Corporate announcements 17
- 14 Oct 2026Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015
- 8 Oct 2026Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015
- 7 Oct 2026Press Release / Media Release
Quarterly results 1
Conference calls 2
- 21 Sep 2026Analyst / Investor Meet - Intimation
- 10 Sep 2026Analyst / Investor Meet - Intimation
Investor presentations 0
None in the filings we hold.
Members see every filing, and what each means for the company in Corporate Intelligence.
The full Company File
- Price, P/E, P/B & returns charts
- Growth vs last year, explained
- Cash from operations vs profit
- Accounts checks
- Who owns it
- 8 quarters, balance sheet & cash flow
- Every BSE filing, in four panels
- Excel & CSV downloads
Education & analysis only, not investment advice or a recommendation.